[Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination].
Galenko-Iaroshevskiĭ
P A
PA
Khankoeva
A I
AI
Uvarov
A V
AV
Bartashevich
V V
VV
Popov
P B
PB
Sirotenko
D V
DV
Boldin
V B
VB
D000638:Amiodarone / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000633:toxicity*; D001549:Benzamides / Q000494:pharmacology*; D001562:Benzimidazoles / Q000633:toxicity; D002316:Cardiotonic Agents / Q000494:pharmacology*; D003984:Dibenzazepines / Q000633:toxicity; D004336:Drug Antagonism; D004562:Electrocardiography; D008012:Lidocaine / Q000633:toxicity; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D011342:Procainamide / Q000633:toxicity; D011433:Propranolol / Q000633:toxicity; D051381:Rats; D017208:Rats, Wistar; D013386:Succinates / Q000494:pharmacology*; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000494:pharmacology; D014700:Verapamil / Q000633:toxicity
C110746:9-diethylaminoethyl-2-tert-butylimidazo(1,2-a)benzimidazol; D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D001562:Benzimidazoles; D002316:Cardiotonic Agents; D003984:Dibenzazepines; D009025:Morpholines; D013386:Succinates; C107888:sufan; C059049:befol; D014364:Tryptophan; D008012:Lidocaine; C048166:tiracizine; D011433:Propranolol; D014700:Verapamil; D011342:Procainamide; D000638:Amiodarone